- Current report filing (8-K)
September 09 2009 - 3:45PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 9, 2009
Nyer
Medical Group, Inc.
(Exact
name of registrant as specified in its charter)
Commission
File Number: 00-20175
|
|
|
Florida
|
|
01-0469607
|
(State
or other jurisdiction
of
incorporation)
|
|
(IRS
Employer
Identification
No.)
|
13
Water Street, Holliston, MA 01746
(Address
of principal executive offices, including zip code)
(508)
429-8506
(Registrant’s
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
4.02.
|
Non-reliance
on previously issued financial statements or a related audit report or
completed interim review.
|
On
September 2, 2009, the Audit Committee of the Board of Directors (“Audit
Committee”) of Nyer Medical Group, Inc. (the “Company” or “Nyer”)
concluded that the Company’s financial statements and related audit reports
thereon for the year ended June 30, 2008, in the Company’s most recently filed
Annual Report on Form 10-K for the year ended June 30, 2008, and the interim
financial statements for the quarters ended December 31, 2007, and March 31,
2008, in the Quarterly Reports on Form 10-Q for the quarters ended December 31,
2007, March 31, 2008, December 31, 2008, and March 31, 2009, should no
longer be relied upon due to errors in the Company’s accounting for transaction
costs associated with the purchase of the minority interest in DAW, Inc. , now a
wholly owned subsidiary of the Company, in February 2008. Management
had discovered these errors during its preparation of the Company’s financial
statements for the year ended June 30, 2009. Management then
discussed the errors with the Audit Committee, which also consulted with the
Company’s current independent registered public accounting firm and the
independent registered public accounting firm engaged by the Company for the
year ended June 30, 2008, and through March 16, 2009, regarding the matters
disclosed in this Current Report on Form 8-K.
The
errors related to transaction costs that were expensed in the Company’s
Consolidated Statement of Operations in the quarters ended December 31, 2007,
and March 31, 2008. These costs should have resulted in additional
goodwill pursuant to the purchase price allocation. As a result of
this error, selling, general, and administrative expenses were overstated and
net income was understated, net of related tax effect, for the quarters
ended December 31,2007, and March 31, 2008, and the year ended June 30,
2008.
Management
is in the process of finalizing an analysis of the aggregate amount of these
costs and their effect on the filings listed above. Upon completion
of the analysis, the Company intends to restate amounts previously reported and
amend prior filings as determined necessary.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
Nyer
Medical Group, Inc.
|
|
|
|
|
|
|
|
|
|
Date:
September 9, 2009
|
|
By:
|
|
|
|
|
|
|
|
Mark
A. Dumouchel
|
|
|
|
|
|
President
and Chief Executive Officer
|
|
Nyer Medical (NASDAQ:NYER)
Historical Stock Chart
From Apr 2024 to May 2024
Nyer Medical (NASDAQ:NYER)
Historical Stock Chart
From May 2023 to May 2024